Pharmacokinetics of vancomycin when administered during high flux hemodialysis

Clinical Nephrology

Volumn 50, Issue 1, 1998, Pages 51-55

  Foote, E F ^a,b   Dreitlein, W B ^a   Steward, C A ^b   Kapoian, T ^b   Walker, J A ^b   Sherman, R A ^b  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Dialysis membranes; Hemodialysis; Pharmacokinetics; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; POLYSULFONE; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIALYSATE; DIALYSIS MEMBRANE; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG MONITORING; FEMALE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE;

EID: 0031827212     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Barth RH, DeVincenzo N 1996 Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy. Kidney Int 50: 929-936
2. Bohler J, Reetze-Bonorden P, Keller E, Kramer A, Schollmeyer PJ 1992 Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes. Eur J Clin Pharmacol 42: 635-639
3. DeSoi CA, Sahm DF, Umans JG 1992 Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes. Am J Kidney Dis 20: 354-360
4. Follin SZ, Mueller BA, Scott MK, Carfagna MA, Kraus MA 1996 Falsely elevated serum vancomycin concentrations in hemodialysis patients. Am J Kidney Dis 27: 67-74
5. Lanese DM, Alfrey PS, Molitoris BA 1989 Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. Kidney Int 35: 1409-1412
6. Matzke GR 1992 Vancomycin. In: Evans WE, Schentag JJ, Jusko WJ (eds). Applied pharmacokinetics. Principles of therapeutic drug monitoring. Applied Therapeutics, Inc. Vancouver, pp 1-31
7. Pollard TA, Lampasona V, Akkerman S, Tom K, Hooks MA, Mullins RE, Maroni BJ 1994 Vancomycin redistribution: dosing recommendations following high-flux hemodialysis. Kidney Int 45: 232-237
8. Quale JM, O'Halloran JJ, DeVincenzo N, Barth RH 1992 Removal of vancomycin by high-flux hemodialysis membranes. Antimicrob Agents Chemother 36: 1424-1426
9. Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA 1997 Effects of dialysis membranes on intradialytic vancomycin administration. Pharmacotherapy 17: 256-262
10. Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J 1991 Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile [see comments]. Clin Nephrol 36: 35-41
11. Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ 1995 Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease. Am J Kidney Dis 26: 469-474
12. Welage LS, Mason NA, Hoffman EJ, Odeh RM, Dombrouski J, Patel JA, Swartz RD 1995 Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics. J Am Soc Nephrol 6: 1284-1290